shot-button
Subscription Subscription
Home > Entertainment News > Bollywood News > Article > Amol Palekar admitted to Pune hospital with Covid 19 condition stable

Amol Palekar admitted to Pune hospital with Covid-19, condition stable

Updated on: 10 February,2022 10:26 AM IST  |  Pune
IANS |

The 77-year-old actor's condition is said to be stable

Amol Palekar admitted to Pune hospital with Covid-19, condition stable

Amol Palekar/picture courtesy:mid-day archives

Bollywood's Everyman of the 1970s, veteran actor and director Amol Palekar, known for Hindi classics such as 'Rajnigandha', 'Chitchor' and 'Gol Maal', has been admitted to the Dinanath Mangeshkar Hospital here because of Covid-19.


Palekar has also worked and contributed to Marathi mainstream films and parallel cinema made his debut in 1971 with the film 'Shantata! Court Chalu Aahe'. He then stepped into Bollywood with Basu Bhattacharya's 'Rajnigandha' opposite Rakhee in 1974.


He was popular for starring in "middle-class family comedies" such as 'Gol Maal' and 'Naram Garam', and was also seen in films such as 'Gharonda', 'Shrimaan Shrimati', 'Rang Birangi', and 'Bhumika'.


This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK